Research · Explainer

The Tuskegee syphilis study and how it changed research ethics

The Tuskegee syphilis study followed Black men without informed consent, withheld penicillin after it became available, and helped trigger US reforms requiring voluntary consent and independent ethics review (CDC History, 2024; CDC Ethics, 2024). The difference between what participants were told and what investigators did lies at the centre of the case (CDC Timeline, 2024).

Records document recruitment, observation and treatment denied, followed by public investigation and subsequent federal regulation. Official CDC accounts and federal ethics documents establish the sequence, while historical scholarship and later population studies test claims about mistrust. They answer different questions. A historical event can be documented from contemporary files, while attitudes decades later require measurements of people who were never enrolled.

Unmarked paper medical records, glass bottles and a stethoscope in a historical clinic room
An unmarked medical file, glass bottles and stethoscope on an old clinic desk Editorial illustration

What the Tuskegee syphilis study was

The U.S. Public Health Service began the study in Macon County, Alabama, to observe the course of untreated syphilis in Black men. The investigation ran from 1932 until 1972, according to the CDC's historical account (CDC History, 2024). Observation of disease over time was the stated scientific purpose. Informed consent was not collected, and treatment was withheld after it became available (CDC History, 2024).

Study purpose and participants

The CDC Timeline (2024) records 600 Black men at enrolment, 399 with syphilis and 201 without it. Those men served as controls. Historian Allan Brandt described the study's purpose as following the natural course of untreated latent syphilis, while his 1978 historical account used rounded figures of 400 affected men and 200 controls (Brandt, 1978). The CDC provides the more specific counts.

The investigators observed untreated disease (Brandt, 1978). Syphilis was present in one enrolled group, and the other group did not have the disease (CDC Timeline, 2024). Enrolment was not deliberate infection. The records describe the enrolment of men with and without infection, followed by observation of those with syphilis (CDC Timeline, 2024; CDC History, 2024).

Recruitment and promises of care

The men were told they were receiving treatment for 'bad blood', a local description covering several ailments, including syphilis, anaemia and fatigue (CDC Timeline, 2024). They were offered medical examinations, meals and burial insurance. Such benefits provided a reason to remain in contact with the study, but the reported explanation concealed its actual purpose (CDC Timeline, 2024; CDC History, 2024).

A participant who believed examinations were part of treatment lacked the information needed to evaluate continued observation without therapy. The CDC states that consent was not obtained and that available treatment was not offered (CDC History, 2024). Examinations continued without treatment. A separate history of [syphilis serology and cardiolipin](/health/cardiolipin-standardization-syphilis-serology-health) concerns the development of diagnostic testing, whereas Tuskegee concerned the withholding of treatment during medical observation.

What happened during the Tuskegee syphilis study

Medical treatment changed during the study. Brandt's 1978 account describes published reports beginning in 1936, followed by further papers appearing every four to six years through the 1960s (Brandt, 1978). Publication did not confer informed consent. The CDC's account makes the lack of informed consent explicit (CDC History, 2024).

Observing untreated illness

Researchers followed the natural history of untreated syphilis (CDC History, 2024). Brandt's analysis identifies the project as observation of latent syphilis in Black men living in Macon County (Brandt, 1978). Such long-term observation acquired a different ethical meaning when a treatment became available and the men still were not offered it. Observation continued (CDC History, 2024).

A published observation may describe disease progression, but its existence does not establish that withholding care was acceptable. The federal inquiry subsequently found the study ethically unjustified and criticised the failure to inform men of their illness and provide treatment (NLM, 2023). Historical assessment therefore has to consider the circumstances in which the observations were gathered. Informed consent was not collected (CDC History, 2024).

Penicillin and withheld treatment

According to the CDC timeline, penicillin had become the treatment of choice for syphilis by 1943 and was becoming widely available (CDC Timeline, 2024). The participants were nevertheless not offered it. Brandt reported that Public Health Service officials at times actively sought to prevent treatment, a more specific accusation than passive failure to make care available (Brandt, 1978). The precise history of treatment availability and deliberate obstruction is central to interpreting the study.

The original absence of a cure cannot explain withholding penicillin after its availability. Untreated disease remained the focus (CDC History, 2024). At that point the project depended upon withholding a therapy that could change its observed course. The federal panel later cited the failure to provide treatment after an effective remedy had been found (NLM, 2023).

A timeline of the study

Event

Documented record

1932

The U.S. Public Health Service began the study in Alabama (CDC History, 2024).

1936

First published study report, according to Brandt (1978).

1943

Penicillin was the treatment of choice according to the CDC timeline (CDC Timeline, 2024).

1972

Press coverage prompted an advisory panel; the panel recommended termination (CDC Timeline, 2024).

1974

National Research Act established a federal commission (National Commission, 1979).

1979

Belmont Report set out three research ethics principles (National Commission, 1979).

Study design preceded effective treatment. Later decisions maintained observation without therapy. Legislation followed the termination. The federal reforms belonged to a sequence of institutional responses after the study ended (CDC Ethics, 2024; National Commission, 1979).

Why the Tuskegee study was unethical

The central violations were the failure to obtain informed consent and the decision not to provide treatment after it became available (CDC History, 2024). The federal advisory inquiry later concluded that the study could not be ethically justified (NLM, 2023). Assessing these failures requires attention to the information available to investigators and the information disclosed to the participants. Investigators controlled access to treatment.

The CDC reports that informed consent was not obtained, while recruitment described the activity as treatment for 'bad blood' (CDC History, 2024; CDC Timeline, 2024). The participants could therefore agree to examinations without being informed about the research's purpose or the withholding of care. Voluntary attendance for an examination was not equivalent to a properly informed decision to participate in a study of untreated disease. The difference follows from the reported deception and absence of consent.

The Belmont Report described respect for persons as recognising individual autonomy and protecting those with diminished autonomy (National Commission, 1979). This framework helps explain why access to meaningful information is a requirement for research participation. Informed choice requires relevant information. In Tuskegee, withholding information was documented alongside withholding therapy (CDC History, 2024).

Deception and unequal treatment

The study enrolled Black men in Alabama and described continued examinations as a health service (CDC Timeline, 2024). The racial composition of the group is a documented feature, while the ethical criticism concerns the participants' inability to give informed consent and the lack of access to treatment (CDC History, 2024). Brandt's 1978 historical investigation placed the study under the heading of racism and research and detailed attempts to obstruct treatment (Brandt, 1978).

The federal inquiry's conclusion concerns a specific set of decisions, including failing to inform participants and withholding care once effective therapy existed (NLM, 2023). Longitudinal observations were collected without informed consent (CDC History, 2024). The benefits of scientific information had to be weighed against known risks to the people supplying it, a concern articulated in the Belmont framework (National Commission, 1979).

How the Tuskegee study ended in 1972

National reporting preceded the study's termination (CDC Timeline, 2024). The sequence matters because the experiment had been operating for decades before an official panel recommended its termination (CDC History, 2024; CDC Timeline, 2024). Public exposure came before federal review. Neither should be treated as evidence that the programme had previously been unknown to all officials.

Whistleblowing and press coverage

The Associated Press published a story about the study in 1972, followed by the appointment of a federal advisory panel (CDC Timeline, 2024). Tobin (2022) describes how Peter Buxtun challenged the study in correspondence in November 1968 and how officials convened an internal panel in February 1969. He later contacted a journalist; the story appeared in the Washington Star on 25 July 1972 (Tobin, 2022).

Scientific reports preceded public scrutiny. Brandt traced publications from 1936 through the 1960s (Brandt, 1978). Publication alone did not protect participants. It was the later exposure and advisory process that preceded termination (CDC Timeline, 2024).

Federal investigation and termination

The Assistant Secretary for Health and Scientific Affairs convened an ad hoc panel following reporting on the study (CDC History, 2024). The panel advised stopping it during October of 1972; the Assistant Secretary announced its end the following month (CDC Timeline, 2024). The review followed the press coverage. The federal findings also condemned the failure to provide information and treatment (NLM, 2023).

Later historical work drew on surviving correspondence, meeting records and reports. The National Library of Medicine announced public access to a digitised collection containing more than 3,000 reproduced documents in 2023 (NLM, 2023). Such records allow historians to investigate individual decisions rather than relying on a single retrospective description. The archive documents the institutional setting; it does not turn later interpretations into direct testimony from every participant.

How Tuskegee changed research ethics

After Tuskegee, federal authorities changed rules governing human research, including procedures for informed consent and independent review (CDC Ethics, 2024). The National Research Act created a commission to consider protections for research participants, and the Belmont Report later stated principles for evaluating human studies (National Commission, 1979). These were related developments with distinct functions. The law created the commission that developed the ethical framework.

The National Research Act

The National Research Act was signed into law on 12 July 1974, creating the National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research (National Commission, 1979). Its remit included identifying underlying ethical principles and guiding research involving people. The commission examined informed consent, the selection of research participants, and the assessment of risks and benefits (National Commission, 1979).

The legislation followed Tuskegee's termination. Ethical concerns about experimenting on people had existed before the study was exposed. Earlier ethical thinking and institutional debate informed later protections. The Tuskegee disclosures became part of the historical setting in which research rules were revised (CDC Ethics, 2024).

The CDC Ethics account (2024) states that, from 1974, studies conducted or funded by the US Department of Health, Education, and Welfare (DHEW) required voluntary informed consent, while DHEW-supported studies involving human participants required review by institutional review boards (IRBs). IRBs assess research protocols against ethical requirements. The aim is to examine the proposed conditions of participation before or during research, rather than depending on publicity after harms emerge (CDC Ethics, 2024).

Consent governs the participant’s choice, while independent review examines the design and management of a study. Tuskegee shows how the failures can coincide: men were misled about the research and were denied treatment after its availability (CDC Timeline, 2024; CDC History, 2024). Attendance did not establish consent. Federal reforms required independent scrutiny.

The Belmont Report principles

Published in 1979, the Belmont Report articulated respect for persons, beneficence and justice (National Commission, 1979). Respect for persons concerned autonomy and protection where autonomy was diminished. The report also discussed informed consent, assessment of risks and benefits, and the selection of subjects as applications of its ethical principles (National Commission, 1979).

Those applications address failures visible in Tuskegee. The investigators denied informed consent and treatment to enrolled Black men (CDC Timeline, 2024; CDC History, 2024; National Commission, 1979). The Belmont framework came later. Other historical [science classics involving population studies](/research/seven-countries-coronary-heart-disease-science-classic-research) pose different questions about inference through their designs.

The Tuskegee study and mistrust in medical research

The study is frequently invoked to explain mistrust of medical institutions, but the historical and empirical claims need separation. Historian Vanessa Gamble argued in 1997 that mistrust among African Americans preceded public exposure of Tuskegee and arose within a broader set of historical experiences (Gamble, 1997). The study's documented abuses therefore form part of the history without furnishing a complete explanation of every later attitude. The 2009 survey measured reported willingness to participate (Katz et al., 2009).

Historical roots of mistrust

Gamble's 1997 analysis challenged the argument that a single revelation created mistrust. Her historical account treated the relationship between African Americans and biomedical institutions as having developed before the Tuskegee disclosures (Gamble, 1997). The distinction is chronological: attitudes already present cannot all be attributed to an event revealed later. The analysis also leaves room for later information about the study to alter perceptions.

Tuskegee itself provided documented reasons for distrust. Participants were told they were receiving treatment and were not given informed consent (CDC Timeline, 2024; CDC History, 2024). The lack of treatment remained part of the documented abuse (CDC Timeline, 2024). Their influence on any later individual remains uncertain.

What later studies can establish

Katz and colleagues examined the Tuskegee legacy in a 2009 telephone survey of 1162 Black, white and Puerto Rican Hispanic adults in three US cities. Awareness of the Tuskegee study was not statistically associated with willingness to participate in biomedical research in that survey (Katz et al., 2009). This is a study-specific negative finding. It does not demonstrate that mistrust was absent or that knowledge of Tuskegee had no influence in any setting.

Alsan and Wanamaker examined changes associated with the 1972 disclosure using a quasi-experimental comparison of demographic groups and distance from the study's participants. Their 2018 analysis found that disclosure was correlated with increased medical mistrust and mortality and fewer physician interactions among older Black men (Alsan and Wanamaker, 2018). The study measured behavioural and health patterns, whereas Katz and colleagues measured reported willingness to join biomedical studies. Their outcomes are different and need not move together.

The designs differ. A telephone survey can test an association between reported awareness and an expressed willingness, while an observational historical comparison considers changes across groups and periods. The [accuracy of self-reported participation measures](/research/accuracy-of-self-reported-participation-rates-research) is a related methodological problem, although it concerns a different activity. Neither study establishes a universal reaction to the Tuskegee disclosure.

What is proven about the Tuskegee study and what is not

The study continued after effective treatment became available, without informed consent from the men enrolled to observe untreated syphilis (CDC History, 2024). The subsequent reforms included federal consent requirements, independent review and a national ethics framework (CDC Ethics, 2024; National Commission, 1979). These decisions have documentary records. Claims about every person's later trust in medicine require different kinds of evidence.

Tuskegee's documented ethical failure involved informed consent and withheld treatment; later studies of medical mistrust report different results for different populations and outcomes (CDC History, 2024; Gamble, 1997; Katz et al., 2009).

An official historical account describes the enrolment of Black men with and without syphilis. It does not describe the study as an experiment in which investigators deliberately infected those men (CDC Timeline, 2024; CDC History, 2024). Treatment was still withheld. It prevents an inaccurate account of the study's design from displacing its actual failures.

The chronology of regulation is established by government records. The National Research Act was signed in 1974, and the Belmont Report followed in 1979 (National Commission, 1979). Those changes addressed research conducted with people, including their informed decisions and the scrutiny of risk. The rule changes did not themselves measure whether the public's confidence in medical institutions recovered.

On mistrust, the available evidence gives different answers to different questions. Gamble's historical analysis places mistrust before Tuskegee's public exposure, while Katz and colleagues found no statistically significant relationship between awareness and stated willingness to participate in their surveyed cities (Gamble, 1997; Katz et al., 2009). Alsan and Wanamaker found associations involving physician use and mortality among older Black men following disclosure (Alsan and Wanamaker, 2018). These are population-specific findings, not a single estimate of the event's psychological effects on all Americans.

The archive contains contemporary documents. The National Library of Medicine's digitised collection includes more than 3,000 reproduced records, covering correspondence, reports and meeting materials (NLM, 2023). Such records document institutional decisions. Assessing subsequent attitudes requires studies that identify participants, outcomes and the ways knowledge of the event was measured.

Frequently asked questions

Were participants deliberately infected with syphilis?

The CDC describes enrolment of men who already had syphilis alongside men who did not have the disease (CDC Timeline, 2024). Its history does not identify deliberate infection as the study procedure. The documented ethical violations were the absence of informed consent and the withholding of treatment once it was available (CDC History, 2024).

How many men were enrolled in the Tuskegee study?

The CDC records 600 Black men at enrolment, including 399 with syphilis and 201 without it (CDC Timeline, 2024). Brandt's 1978 history described approximately 400 affected men and 200 controls (Brandt, 1978). The CDC provides the specific enrolment counts (CDC Timeline, 2024).

When did penicillin become available for syphilis?

The CDC timeline states that penicillin had become the treatment of choice by 1943 and was becoming widely available (CDC Timeline, 2024). The men participating in the study were not offered that treatment. Brandt's historical account describes occasions when officials sought to prevent treatment even after penicillin was widely available (Brandt, 1978).

What is the difference between the Belmont Report and the Nuremberg Code?

The Belmont Report identified respect for persons, beneficence and justice (National Commission, 1979). The Nuremberg Code was already promulgated while the Tuskegee study continued, although Tobin (2022) found no evidence it was used to assess the project at the time. The Belmont framework applied its principles to informed consent, risk assessment and subject selection (National Commission, 1979).

Did the Tuskegee study involve women?

No women were included among the research participants, according to the CDC (CDC History, 2024). The study enrolled Black men with and without syphilis, but the consequences were not limited to those men. The CDC states that some women contracted syphilis from men in the infected group because treatment was withheld (CDC History, 2024).

Sources

  1. Centers for Disease Control and Prevention. The Untreated Syphilis Study at Tuskegee Timeline. 4 September 2024. https://www.cdc.gov/tuskegee/about/timeline.html
  2. Brandt AM. Racism and Research: The Case of the Tuskegee Syphilis Study. Hastings Center Report. 1978;8(6):21–29. DOI 10.2307/3561468
  3. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. American Journal of Public Health. 1997;87(11):1773–1778. DOI 10.2105/AJPH.87.11.1773.
  4. Centers for Disease Control and Prevention. About The Untreated Syphilis Study at Tuskegee. 4 September 2024. https://www.cdc.gov/tuskegee/about/index.html
  5. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. 18 April 1979. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/read-the-belmont-report/index.html
  6. Katz RV, Green BL, Kressin NR, et al. Exploring the legacy of the Tuskegee Syphilis Study: a follow-up study from the Tuskegee Legacy Project. Journal of the National Medical Association. 2009;101(2):179–183. DOI 10.1016/S0027-9684(15)30833-6.
  7. Alsan M, Wanamaker M. Tuskegee and the Health of Black Men. Quarterly Journal of Economics. 2018;133(1):407–455. DOI 10.1093/qje/qjx029.
  8. National Library of Medicine. Digitized Document Collection from USPHS Untreated Syphilis Study at Tuskegee Now Publicly Available Through NLM. 19 October 2023. https://www.nlm.nih.gov/news/Collection-Untreated-Syphilis-Study-Tuskegee.html
  9. Centers for Disease Control and Prevention. Effects on Research. 4 September 2024. https://www.cdc.gov/tuskegee/about/effects-research.html
  10. Tobin MJ. Fiftieth Anniversary of Uncovering the Tuskegee Syphilis Study: The Story and Timeless Lessons. American Journal of Respiratory and Critical Care Medicine. 2022;205(10):1145–1158. DOI 10.1164/rccm.202201-0136SO.
Clara Whitmore

Clara Whitmore — author

Clara Whitmore writes with an editorial focus on historically important scientific studies, older research methods and the development of scientific concepts over time. At Cabdirect, Clara covers classic experiments, historical research and the changing interp...

Related